Titre : | International Journal of Drug Policy, Vol.105 - July 2022 |
Type de document : | Bulletin : Périodique |
Paru le : | 01/07/2022 |
Année de publication : | 2022 |
Langues: | Anglais |
Note de contenu : |
CONTENTS:
- Diverting people who use drugs from the criminal justice system: A systematic review of police-based diversion measures. Blais E., Brisson J., Gagnon F., Lemay S.-A., art. 103697. - The transition of alcohol control in China 1990-2019: Impacts and recommendations. Hu A., Jiang H., Dowling R., Guo L., Zhao X., Hao W., et al., art. 103698. - 'Red Flags' and 'Red Tape': Telehealth and pharmacy-level barriers to buprenorphine in the United States. Textor L., Ventricelli D., Aronowitz S.V., art. 103703. - Manifest your desires: Psychedelics and the self-help industry. Plesa P., Petranker R., art. 103704. - You've got mail: Drinks are on sale! A study to assess volume and content of direct marketing received from online alcohol retailers in Australia. Colbert S., Wilkinson C., Feng X., Thornton L., Richmond R., art. 103705. - Declining prevalence of current HCV infection and increased treatment uptake among people who inject drugs: The ETHOS Engage study. Valerio H., Alavi M., Conway A., Silk D., Treloar C., Martinello M., et al., art. 103706. - Changes in the unregulated opioid drug supply during income assistance payment weeks in Vancouver, Canada: An exploratory analysis. Beaulac M., Richardson L., Tobias S., Lysyshyn M., Grant C., Ti L., art. 103707. - Self-reported challenges obtaining ongoing prescription opioids among Australians with chronic non-cancer pain. Hopkins R.E., Campbell G., Degenhardt L., Lintzeris N., Larance B., Nielsen S., et al., art. 103708. - Factors associated with 60-day adherence to "safer supply" opioids prescribed under British Columbia's interim clinical guidance for health care providers to support people who use drugs during COVID-19 and the ongoing overdose emergency. Selfridge M., Card K., Kandler T., Flanagan E., Lerhe E., Heaslip A., et al., art. 103709. - Impact of COVID-19 on substance use disorder treatment services in Kenya: Qualitative findings from healthcare providers. Muller A., Akiyama M.J., Riback L., Nyakowa M., Musyoki H., Cherutich P., et al., art. 103710. - The importance of PEOPLE who use drugs within drug policy reform debates: Findings from the UK Drug Policy Voices online survey. Askew R., Griffiths B., Bone M., art. 103711. - Assessing options for cannabis law reform: A Multi-Criteria Decision Analysis (MCDA) with stakeholders in New Zealand. Wilkins C., Rychert M., Queirolo R., Lenton S.R., Kilmer B., Fischer B., et al., art. 103712. - "There are solutions and I think we're still working in the problem": The limitations of decriminalization under the good Samaritan drug overdose act and lessons from an evaluation in British Columbia, Canada. Xavier J., Greer A., Pauly B., Loyal J., Mamdani Z., Ackermann E., et al., art. 103714. - A mixed methods study of provider factors in buprenorphine treatment retention. Gertner A.K., Clare H.M., Powell B.J., Gilbert A.R., Jones H.E., Silberman P., et al., art. 103715. - Trends in the use of cannabis products in Canada and the USA, 2018-2020: Findings from the International Cannabis Policy Study. Hammond D., Goodman S., Wadsworth E., Freeman T.P., Kilmer B., Schauer G., et al., art. 103716. - Controlling for pleasure and risk: The experiences of sexuality and gender diverse people who use GHB. Freestone J., Prestage G., Bourne A., Ezard N., Race K., Nedanoski A., et al., art. 103747. - Permissive regulation: A critical review of the regulatory history of buprenorphine formulations in Canada. Sud A., McGee M., Mintzes B., Herder M., art. 103749. - Response to "Operational and contextual barriers to accessing supervised consumption services in two Canadian cities". Brooks H.L., Speed K., Lopez E., O'Gorman C., Haines-Saah R., Hyshka E., art. 103717. - A rejoinder to Brooks et al. "Response to operational and contextual barriers to accessing supervised consumption services in two Canadian cities". Greene C., Urbanik M.-M., art. 103718. - How (not) to prove that drug checking services facilitate access to difficult-to-reach communities who use drugs, and (not) encourage drug initiation? Calle P., art. 103632. - Reply on comments from Paul Calle on 'Visitors of the Dutch drug checking service: Profile and drug use experience.'. Koning R.P.J., Benschop A., Wijffels C., Noijen J., art. 103684. |
Cote : | Abonnement |
Lien : | https://www.sciencedirect.com/journal/international-journal-of-drug-policy/vol/105 |
Dépouillements
Ajouter le résultat dans votre panierArticle : Périodique
E. BLAIS ;
J. BRISSON ;
F. GAGNON ;
S. A. LEMAY
|
Background: Previous reviews of the effectiveness of measures to divert those who use drugs from the criminal justice system have focused mainly on post-conviction or post-sentence programs and report mixed results. The present systematic review[...]
Exemplaires
Disponibilité |
---|
aucun exemplaire |
Accueil